HUMA

HUMACYTE INC

HUMA·44486Q103·US·Common Stock·Healthcare - Biotechnology-Activist

HUMA (HUMACYTE INC) is held by 80 institutional investors as of Q2 2026. Largest holders: VANGUARD CAPITAL MANAGEMENT LLC ($7.9M), Alyeska Investment Group, L.P. ($4.7M), BlackRock, Inc. ($3.8M). Net institutional sentiment: Mixed. In Q2 2026, 1 member of Congress and 46 funds bought HUMA.

80
Holders
(7 Elite)
$35.9M
Total Value
50% (92)
Consensus
46 buying - 46 selling
13F: Insider & Congress: Updated regularly
HUMA

Smart Money Verdict

View all
Loading verdict
Held by 80 funds
7 elite

Who's Trading

Source dates: Price Aug 18, 2026 · Insiders Aug 20, 2025 · Activists Jul 28, 2026 · Congress Aug 5, 2026

ActivistBlackRock, Inc.BlackRock, Inc.1.5%Jul 28, 2026
ActivistDKDavidson Kempner Capital Management LP4.7%Jun 22, 2026
InsiderDWDougan Brady WSell $935KAug 20, 2025
Checking access…

Top Holders

Checking access…
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
10.1M(+41.2%)$7.9M0.0%-40.97%
37
New
6M$4.7M0.0%-25.42%
37
Decreased
4.8M(-60.7%)$3.8M0.0%-84.84%
0
Increased
2.8M(+2.2%)$2.2M0.0%-77.35%
27
Increased
2.6M(+34.9%)$2M0.0%-42.37%
34
Decreased
2.2M(-40.3%)$1.7M0.0%-83.07%
0
Increased
1.9M(+1665.1%)$1.5M0.0%-30.82%
41
Increased
1.7M(+60.6%)$1.3M0.0%-75.31%
37
New
1.4M$1.1M0.0%-25.42%
35
Increased
1.4M(+4.8%)$1.1M0.0%-83.44%
26
Increased
1.2M(+16.8%)$921,3950.0%-43.43%
29
Increased
1M(+18.6%)$800,3270.0%-77.14%
29
Increased
965,091(+15.9%)$753,1560.0%-74.35%
28
Decreased
842,537(-72.3%)$657,5160.0%-84.73%
0
New
790,000$616,5160.0%-25.42%
34
Decreased
586,524(-13.4%)$457,7230.0%-82.09%
0
Increased
578,592(+46.1%)$451,3030.0%-80.67%
22
Decreased
568,521(-59.9%)$443,4460.0%-45.64%
0
Decreased
500,582(-75.0%)$390,6540.0%-86.54%
0
Decreased
456,473(-62.7%)$356,2310.0%-83.29%
0

Showing 1-20 of 99

1 / 5
HUMAHUMAHUMACYTE INC

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used